SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Elder Pharmaceuticals gains on increasing stake in Elder Biomeda AD, Bulgaria

13 Feb 2012 Evaluate

Elder Pharmaceuticals is currently trading at Rs. 347.00, up by 0.90 points or 0.26% from its previous closing of Rs. 346.10 on the BSE.

The scrip opened at Rs. 352.20 and has touched a high and low of Rs. 352.20 and Rs. 347.00 respectively. So far 17,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 435.00 on 29-Jul-2011 and a 52 week low of Rs. 328.00 on 20-Dec-2011.

Last one week high and low of the scrip stood at Rs. 356.00 and Rs. 344.00 respectively. The current market cap of the company is Rs. 712.00 crore.

The promoters holding in the company stood at 39.60% while Institutions and Non-Institutions held 25.13% and 35.27% respectively.

Elder Pharmaceuticals through its Dubai’s wholly owned subsidiary has increased its stake in Elder Biomeda AD, Bulgaria on February 07, 2012. The company has increased its stake from 92.20% to 100%.

Elder Pharmaceuticals (EPL) has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×